Read more
Molecular Biomarkers in Cancer Detection and Monitoring of Therapeutics: Volume Two: Diagnostic and Therapeutic Applications discusses how molecular biomarkers are used to determine predisposition, facilitate detection, improve treatment and offer prevention guidelines for different cancers. It focuses on novel diagnostic techniques based on molecular biomarkers and their impact on treatment, covering different cancer types such as tumors in the nervous system, head and neck, oral and GI tractor, lung, breast, gastric system, leukemia and urogenital tract cancers. For each type, the book discusses the best diagnostic techniques and therapeutic approaches, thus helping readers easily identify the best solution for each case.
This is a valuable resource for cancer researchers, oncologists, graduate students and other members of the biomedical field who are interested in the potential of biomarkers in cancer research.
List of contents
1. SKIN CANCER BIOLOGY AND ITS BIOMARKERS:RECENT TRENDS AND PROSPECTIVE
Himani Sharma2. ROLE OF BIOMARKERS IN ASSESSING RESPONSE TO IMMUNE CHECKPOINT INHIBITORS IN CANCER TREATMENT
Shyam Aggarwal3. GENOTYPE INFLUENCED PHARMACOKINETICS OF ANTI-CANCER MEDICINE: A CONNECTING LINK
Shamsher Singh4. GENETIC PREDISPOSITION AND PATHOPHYSIOLOGY OF ORAL SQUAMOUS CELL CARCINOMA
Gowtham Kumar Subbaraj5. ORAL SQUAMOUS CELL CARCINOMA
Anubha Gulati6. SHARED AND DISTINCT ASPECTS OF HEMATOPOIETIC MALIGNANCIES SUCH AS LEUKEMIA AND LYMPHOMA
Ramakrishnan Veerabathiran7. MOLECULAR DIAGNOSIS, DRIVERS AND TREATMENT LYMPHOCYTIC LEUKEMIA
Saurabh Yadav8. MYELODYSPLASTIC SYNDROME - A CHALLENGING ENTITY
Anshu Palta9. MULTIPLE MYELOMA
Vijay Goni10. MOLECULAR BIOMARKERS IN PROSTATE CANCER
KATSUNORI UCHIDA and Remi Semba11. GENETICS OF NEURONAL AND GLIONEURONAL CANCERS
Anshika Srivastava12. RECENT ADVANCEMENT IN MOLECULAR MARKER OF PANCREATIC CANCER
Kanagaraj Palaniyandi13. MOLECULAR BIOMARKERS IN GASTRIC CANCER
Yoshifumi S. Hirokawa and Kazuki Kanayama14. MOLECULAR BIOMARKERS IN PANCREATIC DUCTAL ADENOCARCINOMA
Yoshifumi S. Hirokawa, Reiko Yamada and Junya Tsuboi15. BIOMARKERS IN ENDOMTRIAL AND CERVICAL CANCER
Aashima Arora16. BIOMARKERS IN ENDOCRINE DISEASES
Sunil Chumber and Dhritiman Maitra17. CANCER IMMUNOTHERAPY ASSOCIATED ENDOCRINE COMPLICATIONS
Kousik Pramanick18. THERAPEUTIC POTENTIAL OF MELATONIN IN GLIOBLASTOMA: CURRENT KNOWLEDGE AND FUTURE PROSPECTS
Nithar Ranjan Madhu Sr.19. ANTICANCER ACTIVITIES OF MACROMOLECULES OFMARINE ORIGIN: CLINICAL EVIDENCE
Maushmi Shailesh Kumar20. NANOPARTICLES AS A MEANS OF DRUG DELIVERY IN CANCER THERAPY
Olorunfemi Raphael Molehin21. THERAPEUTIC POTENTIAL OF MICROALGAE AND THEIR PROSPECTS IN TARGETED DELIVERY IN CANCER MANAGEMENT
Maushami Kumar and Maushmi Shailesh Kumar22. PROSPECTS OF MANGROVE DERIVED PHYTOCHEMICALS IN CANCER RESEARCH
Punarbasu Choawdhury23. PHYTOCHEMICALS AND MIRNA BASED THERAPEUTIC OPPORTUNITIES FOR CANCER STEM CELL MEDIATED TUMOR ANGIOGENESIS
Anandan Balakrishnan24. EMERGENCE OF METAL-BASED ANTICANCER THERAPEUTICS: A PROMISING PERSPECTIVE
Suman Adhikari25. NEW INFRARED (NIR) RESPONSE NANOMATERIAL LIPOSOME NANOHYBRID FOR CANCER PHOTO THERMAL
Animesh Pan26. IMPACT OF PESTICIDES ON IMMUNE-ENDOCRINE DISORDERS AND ITS RELATIONSHIP TO CANCER DEVELOPMENT
Carolina Panis
About the author
Dr. Ranbir Chander (RC) Sobti is Emeritus Professor at Punjab University, Chandigarh, and Honorary Scientist at the Indian National Science Academy. He started his career as a cytogeneticist and progressed to molecular biology and disease processes of cancer, COPD, AIDS, metabolic syndrome, and kidney diseases. He is a Fellow of the Third World Academy of Sciences, National Academy of Sciences India, Indian National Science Academy, National Academy of Medical Sciences, National Academy of Agricultural Sciences, Canadian Academy of Cardiovascular Diseases Royal Society of biology and international Association of Cancer Research. Dr. Sobti has participated in several book projects, including Elsevier’s Advances in Animal Experimentation and Modeling; Biomarkers in Cancer Detection and Monitoring of Therapeutics; Molecular Medicine and Biomedical Research in the Era of Precision Medicine; One Planet, One Health, One Future; Probiotics; and Public and Environmental Health.Dr.Watanabe graduated from Yokohama National University, Faculty of Engineering (1983), and Mie University, Faculty of Medicine (1989). He obtained a doctor in Medicine from Mie University (1993). He was a professor at Graduate School of Engineering, Yokohama national University (2003-2017), and also a guest professor at School of Medicine, Yokohama City University (2011-1017). He was a visiting fellow in NIH/NIEHS (1997-1999, Dr. J. Carl Barrett). He is now a professor, at School of Medicine, Mir University (2017-). He has published more than 130 scientific publications. He is a member and councilor in Japanese Society of Pathology, and in Japanese Cancer Association.
Aastha Sobti is a Doctoral student at the Department of Immunotechnology at Lund University, Sweden. Her research areas interests include translational medicine, clinical dentistry, cancer immunology, biomarkers, diagnostics and medical oncology. Aastha Sobti has written two books with Elsevier: "Biomarkers in Cancer Detection and Monitoring of Therapeutics" (2023) and Molecular Medicine and Biomedical Research in the Era of Precision Medicine (2025).
